医学
内科学
心脏病学
梗阻性心肌病
中止
梗阻性肥厚性心肌病
肥厚性心肌病
心肌病
心力衰竭
心房颤动
作者
Mengdi Yu,Fang Wang,Lutong Pu,Jie Wang,Yucheng Chen
出处
期刊:CJC open
[Elsevier BV]
日期:2026-01-21
卷期号:8 (5): 531-534
标识
DOI:10.1016/j.cjco.2026.01.006
摘要
LVOT: left ventricular outflow tract HOCM: hypertrophic obstructive cardiomyopathy NYHA: New York Heart Association CMR: Cardiovascular magnetic resonance LV: left ventricular EF: ejection fraction J o u r n a l P r e -p r o o f Mavacamten, a cardiac myosin inhibitor, alleviates left ventricular outflow tract (LVOT) obstruction in patients with hypertrophic obstructive cardiomyopathy (HOCM).We report the clinical course of a 72-year-old female with HOCM treated with mavacamten.After initial symptomatic and hemodynamic improvement, the patient discontinued the drug, leading to the recurrence.Upon reinitiating mavacamten approximately 1.5 years later, she again achieved significant clinical and hemodynamic improvement.This case demonstrates that reinitiation after prolonged discontinuation remains effective, highlighting the importance of continuous, long-term treatment guided by echocardiographic assessment, including the Valsalva-provoked LVOT pressure gradient.J o u r n a l P r e -p r o o f
科研通智能强力驱动
Strongly Powered by AbleSci AI